{"id":11322,"date":"2026-02-18T05:57:33","date_gmt":"2026-02-18T05:57:33","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/11322\/"},"modified":"2026-02-18T05:57:33","modified_gmt":"2026-02-18T05:57:33","slug":"roches-gen-6-troponin-t-test-accurately-diagnosing-heart-attacks","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/11322\/","title":{"rendered":"Roche\u2019s Gen 6 Troponin T test accurately diagnosing heart attacks"},"content":{"rendered":"<p>Roche Holdings AG reported results from its TSIX study which demonstrated that its sixth-generation Troponin T test is accurate at diagnosing heart attacks not only in men but also women. Recently granted CE mark, the Elecsys Troponin T hs Gen 6 test, demonstrated it was able to identify acute myocardial infarction (AMI) and identify those not having an AMI, with a high level of precision, ensuring that patients receive the care they need at the earliest opportunity.<\/p>\n<p><a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/85-medical-technology\" rel=\"nofollow noopener\" target=\"_blank\">Medical technology<\/a> <a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/325-diagnostics\" rel=\"nofollow noopener\" target=\"_blank\">Diagnostics<\/a> <a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/240-cardiovascular\" rel=\"nofollow noopener\" target=\"_blank\">Cardiovascular<\/a> <a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/396-europe\" rel=\"nofollow noopener\" target=\"_blank\">Europe<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Roche Holdings AG reported results from its TSIX study which demonstrated that its sixth-generation Troponin T test is&hellip;\n","protected":false},"author":2,"featured_media":11323,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[124],"tags":[8552,4176,8295,8296,3750,1176,8555,197,8553,8294,8297,134,6399,8554],"class_list":["post-11322","post","type-post","status-publish","format-standard","has-post-thumbnail","category-roche","tag-acute-myocardial-infarction","tag-bioworld-medtech","tag-cachexia","tag-cancer-induced-cachexia","tag-cardiovascular","tag-diagnostics","tag-elecsys","tag-europe","tag-heart-attack","tag-helmholtz-diabetes-center","tag-pen-x-acip","tag-roche","tag-roche-holdings-ag","tag-troponin-testing"],"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/11322","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=11322"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/11322\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/11323"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=11322"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=11322"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=11322"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}